JENBURKT PHARMACEUTICALS Financial Statement Analysis
|
||
The Revenues of JENBURKT PHARMACEUTICALS have increased by 10.30% YoY .
The Earnings Per Share (EPS) of JENBURKT PHARMACEUTICALS has increased by 14.78 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
JENBURKT PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524731]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹137 Cr | ₹124 Cr | ₹109 Cr | ₹119 Cr | ₹123 Cr |
Expenses | ₹106 Cr | ₹97 Cr | ₹89 Cr | ₹99 Cr | ₹98 Cr |
Operating Profit (Excl OI) | ₹30 Cr | ₹27 Cr | ₹20 Cr | ₹20 Cr | ₹25 Cr |
Other Income | ₹5.12 Cr | ₹4.95 Cr | ₹4.31 Cr | ₹4.22 Cr | ₹3.45 Cr |
Interest | ₹0.37 Cr | ₹0.43 Cr | ₹0.47 Cr | ₹0.53 Cr | ₹0.39 Cr |
Depreciation | ₹2.26 Cr | ₹1.90 Cr | ₹2.04 Cr | ₹2.30 Cr | ₹1.35 Cr |
Profit Before Tax | ₹33 Cr | ₹30 Cr | ₹22 Cr | ₹21 Cr | ₹27 Cr |
Profit After Tax | ₹25 Cr | ₹22 Cr | ₹17 Cr | ₹15 Cr | ₹20 Cr |
Consolidated Net Profit | ₹25 Cr | ₹22 Cr | ₹17 Cr | ₹15 Cr | ₹20 Cr |
Earnings Per Share (Rs) | ₹55.76 | ₹48.58 | ₹35.96 | ₹32.40 | ₹43.14 |
PAT Margin (%) | 17.99 | 17.98 | 15.10 | 12.51 | 16.14 |
ROE(%) | 20.53 | 20.66 | 18.49 | 18.89 | 28.54 |
ROCE(%) | 26.80 | 26.89 | 23.83 | 25.73 | 36.90 |
Total Debt/Equity(x) | 0.02 | 0.05 | 0.04 | 0.04 | 0.10 |
Key Financials |
||
Market Cap | : | ₹ 326.9 Cr |
Revenue (TTM) | : | ₹ 138.3 Cr |
Net Profit(TTM) | : | ₹ 24.4 Cr |
EPS (TTM) | : | ₹ 55.6 |
P/E (TTM) | : | 13.4 |
Industry Peers & Returns | 1W | 1M | 1Y |
JENBURKT PHARMACEUTICALS | 1.1% | 6.3% | 9.1% |
SUN PHARMACEUTICAL INDUSTRIES | 1.1% | -6.6% | 56.7% |
CIPLA | 0.2% | -4.4% | 54.3% |
DR REDDYS LABORATORIES | 4.3% | 2.6% | 29.9% |
ZYDUS LIFESCIENCES | 2.2% | -4.6% | 86.6% |
DIVIS LABORATORIES | 4.8% | 18.9% | 23.9% |
MANKIND PHARMA | -1.4% | 1.4% | NA |
TORRENT PHARMACEUTICALS | -1.7% | 3% | 65.8% |
LUPIN | 4.1% | 3% | 131.2% |
JENBURKT PHARMACEUTICALS Revenues
[BOM: 524731]
Y-o-Y | 10.30 % |
5 Yr CAGR | 2.76 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹137 Cr | 10.30 | |
Mar2022 | ₹124 Cr | 13.44 | |
Mar2021 | ₹109 Cr | -8.07 | |
Mar2020 | ₹119 Cr | -3.06 | |
Mar2019 | ₹123 Cr | - |
JENBURKT PHARMACEUTICALS Operating Profit
[BOM: 524731]
Y-o-Y | 11.42 % |
5 Yr CAGR | 5.06 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹30 Cr | 11.42 | |
Mar2022 | ₹27 Cr | 37.36 | |
Mar2021 | ₹20 Cr | 0.50 | |
Mar2020 | ₹20 Cr | -20.79 | |
Mar2019 | ₹25 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 1.05 % |
5 Yr CAGR | 2.25 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 22.21% | 1.05 | |
Mar2022 | 21.98% | 21.10 | |
Mar2021 | 18.15% | 9.27 | |
Mar2020 | 16.61% | -18.26 | |
Mar2019 | 20.32% | - |
JENBURKT PHARMACEUTICALS Profit After Tax
[BOM: 524731]
Y-o-Y | 10.36 % |
5 Yr CAGR | 5.59 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹25 Cr | 10.36 | |
Mar2022 | ₹22 Cr | 35.12 | |
Mar2021 | ₹17 Cr | 10.98 | |
Mar2020 | ₹15 Cr | -24.89 | |
Mar2019 | ₹20 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 0.06 % |
5 Yr CAGR | 2.75 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 17.99 % | 0.06 | |
Mar2022 | 17.98 % | 19.07 | |
Mar2021 | 15.1 % | 20.70 | |
Mar2020 | 12.51 % | -22.49 | |
Mar2019 | 16.14 % | - |
JENBURKT PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524731]
Y-o-Y | 14.78 % |
5 Yr CAGR | 6.63 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹56 | 14.78 | |
Mar2022 | ₹49 | 35.09 | |
Mar2021 | ₹36 | 10.99 | |
Mar2020 | ₹32 | -24.90 | |
Mar2019 | ₹43 | - |
JENBURKT PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524731]
Y-o-Y | -0.33 % |
5 Yr CAGR | -7.68 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 26.8% | -0.33 | |
Mar2022 | 26.89% | 12.84 | |
Mar2021 | 23.83% | -7.38 | |
Mar2020 | 25.73% | -30.27 | |
Mar2019 | 36.9% | - |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Current Share Price | : | ₹743.1 |
Current MarketCap | : | ₹ 326.9 Cr |
Updated EOD on | : | Apr 30,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | 1.1% |
6.3% |
9.1% |
SENSEX | 1% |
2.8% |
23.9% |
JENBURKT PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about JENBURKT PHARMACEUTICALS Financials
How the annual revenues of JENBURKT PHARMACEUTICALS have changed ?
The Revenues of JENBURKT PHARMACEUTICALS have increased by 10.30% YoY .
How the Earnings per Share (EPS) of JENBURKT PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of JENBURKT PHARMACEUTICALS has increased by 14.78 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs